期刊文献+

对吉兰-巴雷综合征的新认识 被引量:8

New understandings of Guillian- Barre syndrome
下载PDF
导出
摘要 吉兰-巴雷综合征(Guillian-Barre syndrome,GBS)是脊髓灰质炎消火后最常见的小儿急性迟缓性瘫痪性疾病,主要表现为快速进展的瘫痪、腱反射消失和脑脊液蛋白细胞分离。根据病理和神经电生理特点,可将其分为4种主要亚型:急性炎症性脱髓鞘性多发性神经炎(acute inflammatory demyelinating polyneuropathy, AIDP)、急性运动轴索性神经病(acute motor axonal neuropathy,AMAN)、急性运动感觉轴索性神经病(acute motor- sensory axonal neuropaty,AMSAN)和Miller-Fisher综合征(MFS)。目前一致认为它是一种免疫介导的器官特异性周围神经病,体液免疫和细胞免疫不同程度地参与了各个亚型病变的发生。根据其典型临床表现及神经传导功能检测,不仅能明确GBS的诊断,还有助于临床分型。免疫调节治疗能有效地缓解神经损伤,加速患者恢复。文章着重介绍近年有关该病的分型、病因及发病机制、临床及电生理特征、鉴别诊断和治疗方面的研究进展。 Guillian-Barré syndrome (GBS) is the most frequent cause of acute flaccid paralysis in the post-polio era, which is characterized clinically by rapidly progressing paralysis, areflexia, and albumino-cytological dissociation in cerebral-spinal fluids. Based on the electroneurophysiologic and pathologic characteristics, this disorder could be classified into four different patterns such as acute inflammatory demyelinating polyneuropathy, acute motor axonal neuropathy, acute motor sensory axonal neuropathy, and the Miller-Fisher syndrome. It was commonly considered that GBS is an organ specific immune-mediated peripheral neuropathy, both cell-mediated and humoral immune pathways variably contribute to the pathogenesis of each pattern. Typical clinical manifestations and nerve conduction studies may help in correct diagnosis and classification of suspected GBS patients. Treatment with immunomedulation can effectively ameliorate nerve damage and accelerate recovery of patients. This review emphasizes the recent advances in understanding of the subtyping, pathogenesis, etiology, clinical features, differential diagnosis, electrophysiological diagnostic criteria and treatment of GBS.
作者 蔡方成
出处 《临床儿科杂志》 CAS CSCD 北大核心 2007年第2期81-84,共4页 Journal of Clinical Pediatrics
关键词 吉兰-巴雷综合征 分型 病因 发病机制 治疗 Guillian - Barré syndrome subtyping etiology pathogenesis treatment
  • 相关文献

参考文献7

  • 1Hughes RA,Cornblath DR.Guillian-Barré syndrome[J].Lancet,2005,366 (9497):1653-1666.
  • 2Kuwabara S.Guillian-Barré syndrome:epidemiology,pathophysiology and management[J].Drugs,2004,64 (6):597-610.
  • 3Yuki N,Susuki K,Koga M,et al.Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillian-Barré syndrome[J].PNAS,2004,101 (31):11404-11409.
  • 4Ryan MM.Guillian-Barré syndrome in childhood[J].J Pediatr Child Health,2005,41(5-6):237-241.
  • 5Willison HJ.The immunobiology of Guillian -Barré syndrome[J].J Peripher Nerv Syst,2005,10(2):94-112.
  • 6Finsterer J.Treatment of immune-mediated,dysimmune neuropathies[J].Acta Neurol Scand,2005,112 (2):115-125.
  • 7蔡方成,钟敏.吉兰-巴雷综合征的研究进展[J].实用儿科临床杂志,2006,21(12):729-731. 被引量:9

二级参考文献17

  • 1向淑利,蔡方成,邓兵,张晓萍.neuB1基因失活空肠弯曲菌突变株的构建及其临床意义[J].中华微生物学和免疫学杂志,2005,25(7):538-543. 被引量:4
  • 2Schwerer B.Antibodies against gangliosides:A link between preceding infection and immunopathogenesis of Guillain-Barre syndrome[J].Microb Infect,2002,4:373-384.
  • 3Schattner A.Consequence or coincidence? The occurrence,pathogene-sis and significance of autoimmune manifestations after viral vaccines[J].Vaccine,2005,23:3876-3886.
  • 4Geleijns K,Schreuder GM,Jacobs BC,et al.HLA class Ⅱ alleles are not a general susceptibility factor in Guillain-Barre syndrome[J].Neurology,2005,64:44-49.
  • 5van der Meche FG,van Doorn PA,Meulstee J,et al.Diagnostic and classification criteria for the Guillain-Barre syndrome[J].Eur Neurol,2001,45:133-139.
  • 6Kieseier BC,Kiefer R,Gold R,et al.Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system[J].Muscle Nerve,2004,30:131-156.
  • 7Newswanger DL,Warren CR.Guillain-Barre syndrome[J].Am Fam Physician,2004,69:2405-2410.
  • 8Ryan MM.Guillain-Barre syndrome in childhood[J].J Paediatr Child Health,2005,41:237-241.
  • 9Oh SJ,Kurokawa K,de Almeida DF,et al.Subacute inflammatory demyelinating polyneuropathy[J].Neurology,2003,61:1507-1512.
  • 10Yuki N.Infectious origins of,and molecular mimicry in,Guillain-Barre and Fisher syndromes[J].Lancet Infect Dis,2001,1:29-37,1187-1407.

共引文献8

同被引文献97

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部